Eguchi A, Nakashima O, Okudaira S, Sugihara S, Kojiro M
First Department of Pathology, Kurume University School of Medicine, Fukuoka-Ken, Japan.
Hepatology. 1992 May;15(5):843-8. doi: 10.1002/hep.1840150516.
The nodular lesions seen in the noncancerous areas of the 80 consecutively resected small hepatocellular carcinoma associated with cirrhosis were pathomorphologically studied. A total of 51 nodular lesions were found, and they were classified into the following four groups: large regenerative nodule (30 nodules), adenomatous hyperplasia (12 nodules), atypical adenomatous hyperplasia (4 nodules) and adenomatous hyperplasia containing cancerous foci (5 nodules). Grossly, all large regenerative nodules were well demarcated, but some of the adenomatous hyperplasia group were vaguely nodular. Atypical adenomatous hyperplasia and adenomatous hyperplasia containing cancerous foci accounted for 43% of the adenomatous hyperplasia group found in the vicinity of the 16 resected hepatocellular carcinoma (20%) out of 80 cases. The mean size (+/- S.D.) of the adenomatous hyperplasias containing cancerous foci, 15.8 +/- 2.2 mm, was significantly larger than 10.1 +/- 2.6 mm of the adenomatous hyperplasias p less than 0.01). All adenomatous hyperplasias containing cancerous foci and 75% of the atypical adenomatous hyperplasias demonstrated a marked fatty change, but none of the large regenerative nodules were accompanied by any fatty changes. This study demonstrated the morphological transition from adenomatous hyperplasia to hepatocellular carcinoma that was suggestive of multistep hepatocarcinogenesis. As a result, it is predicted that approximately 20% of all hepatocellular carcinomas may have the potential for being of multicentric origin and that approximately 40% of adenomatous hyperplasias may undergo malignant transformation, but it is difficult to estimate the exact number of incidences. The presence of varying degrees of fatty change may be one of the significant morphological markers for a malignant transformation from adenomatous hyperplasia to hepatocellular carcinoma.(ABSTRACT TRUNCATED AT 250 WORDS)
对80例连续切除的伴有肝硬化的小肝细胞癌非癌区域所见的结节性病变进行了病理形态学研究。共发现51个结节性病变,分为以下四组:大再生结节(30个结节)、腺瘤样增生(12个结节)、非典型腺瘤样增生(4个结节)和含癌灶的腺瘤样增生(5个结节)。大体上,所有大再生结节界限清楚,但腺瘤样增生组中的一些结节界限模糊。在80例中的16例切除的肝细胞癌(20%)附近发现的腺瘤样增生组中,非典型腺瘤样增生和含癌灶的腺瘤样增生占43%。含癌灶的腺瘤样增生的平均大小(±标准差)为15.8±2.2mm,显著大于腺瘤样增生的10.1±2.6mm(p<0.01)。所有含癌灶的腺瘤样增生和75%的非典型腺瘤样增生均有明显的脂肪变,但大再生结节均无脂肪变。本研究显示了从腺瘤样增生到肝细胞癌的形态学转变,提示肝细胞癌的多步骤发生。结果预测,所有肝细胞癌中约20%可能有多中心起源的潜能,约40%的腺瘤样增生可能发生恶性转化,但难以估计确切的发生率。不同程度脂肪变的存在可能是腺瘤样增生向肝细胞癌恶性转化的重要形态学标志之一。(摘要截断于250字)